Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Cleveland Biolabs (CBLI)

Cleveland Biolabs (CBLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cleveland Biolabs 2537 RESEARCH BOULEVARD SUITE 201 FORT COLLINS CO 80526 USA

www.cytocom.com P: 888-613-8802 F: 716-849-6820

Description:

Cytocom Inc. is a clinical-stage biopharmaceutical company. It involved in developing novel immunotherapies targeting autoimmune, inflammatory, infectious diseases and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. Cytocom Inc., formerly known as Cleveland BioLabs Inc., is based in FORT COLLINS, Colo.

Key Statistics

Overview:

Market Capitalization, $K 49,068
Shares Outstanding, K 15,479
Annual Sales, $ 260 K
Annual Net Income, $ -2,400 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -660 K
60-Month Beta 0.70
% of Insider Shareholders 1.03%
% of Institutional Shareholders 5.09%
Float, K 15,320
% Float 98.97%

Growth:

1-Year Return 68.62%
3-Year Return 67.28%
5-Year Return 78.09%
5-Year Revenue Growth -90.41%
5-Year Earnings Growth 100.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 08/16/21
Earnings Per Share ttm -0.04
EPS Growth vs. Prev Year -33.33%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 01/28/15

CBLI Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.84%
Return-on-Assets % -31.29%
Profit Margin % -923.08%
Debt/Equity 0.00
Price/Sales 201.29
Price/Cash Flow N/A
Price/Book 3.62
Book Value/Share 0.87
Interest Coverage 0.00
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar